Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Anergen issued European patent on AnergiX compounds

June 21, 1996

Antibody production-enhancing peptides described

June 21, 1996

Cyclolignan derivatives disclosed

June 21, 1996

The Salk Institute for Biological Studies reveals immunophilin proteins

June 14, 1996

S-28828: 3M's imiquimod analogue

June 7, 1996

Dimethaid Research announces encouraging results with its immunomodulator

May 31, 1996

Meningococcal protein with vaccine potential

May 31, 1996

Ruthenium complexes revealed by Procept

May 31, 1996

Merck's pediatric pneumococcal conjugate vaccine in advanced trials

May 24, 1996

HPV vaccine in phase I at Merck & Co.

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...